Federated Hermes’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-130
Closed -$2.35K 2066
2025
Q4
$2.35K Buy
+130
New +$1.94K ﹤0.01% 1957
2024
Q3
Sell
-57
Closed -$485 2062
2024
Q2
$485 Buy
+57
New +$857 ﹤0.01% 1974
2024
Q1
Sell
-19
Closed -$243 2033
2023
Q4
$243 Buy
+19
New +$443 ﹤0.01% 2026
2023
Q1
Sell
-7
Closed -$558 2121
2022
Q4
$558 Buy
+7
New +$729 ﹤0.01% 2082
2021
Q2
Sell
-2,179
Closed -$782K 2203
2021
Q1
$782K Buy
+2,179
New +$963K ﹤0.01% 1461
2020
Q3
Sell
-5,330
Closed -$1.94M 2248
2020
Q2
$1.94M Sell
5,330
-110,252
-95% -$27.9M ﹤0.01% 1005
2020
Q1
$24.6M Buy
115,582
+24,203
+26% +$7.68M 0.07% 298
2019
Q4
$37.6M Buy
91,379
+2,352
+3% +$811K 0.08% 265
2019
Q3
$31.4M Buy
89,027
+47,887
+116% +$17.9M 0.08% 263
2019
Q2
$20.7M Buy
41,140
+5,008
+14% +$3.53M 0.05% 342
2019
Q1
$35.9M Buy
36,132
+11,648
+48% +$10.8M 0.09% 245
2018
Q4
$21.3M Buy
24,484
+5,468
+29% +$5.08M 0.06% 306
2018
Q3
$19.7M Hold
19,016
0.05% 357
2018
Q2
$17.5M Sell
19,016
-46
-0.2% -$49.4K 0.05% 291
2018
Q1
$18.6M Buy
+19,062
New +$17.4M 0.05% 264

Other funds holding ATRA